Literature DB >> 25588853

Short-term diabetes- and diuresis-induced alterations of the bladder are mostly reversible in rats.

Nan Xiao1, Yexiang Huang, Michael Kavran, Rania A Elrashidy, Guiming Liu.   

Abstract

OBJECTIVES: To determine whether diabetes mellitus- and diuresis-induced alterations in the bladder can be reversed in rats.
METHODS: Male Sprague-Dawley rats were randomly distributed into eight groups (n = 16 per group): 3 weeks and 11 weeks age-matched controls, 3 weeks and 11 weeks after streptozotocin-induced diabetes mellitus, 3 weeks after diabetes mellitus induction then treated with insulin for 8 weeks, 3 weeks and 11 weeks after 5% sucrose-induced diuresis, and 3 weeks after 5% sucrose-induced diuresis followed by removal of 5% sucrose for 8 weeks. Bodyweight, blood glucose and glycated hemoglobin A1c were monitored. At the designated time-points, 24-h urinary habits were examined, and cystometry was carried out in half of the animals. The bladders from the remaining animals were harvested for histological examination, and quantification of smooth muscle, urothelium and collagen components.
RESULTS: Insulin treatment reversed hyperglycemia and polyuria in diabetic animals successfully, which was shown by normalization of blood glucose, glycated hemoglobin A1c and 24-h urinary habits. Subsequently, bodyweight, bladder weight and percentage change of bladder components (smooth muscle, collagen, urothelium) in total bladder cross-sectional area were reversed to almost normal levels, and the bladder dysfunction was mostly reversed by 8 weeks of glycemic control, seen in the cystometry study. Similar alterations and reversed effects were seen in diuretic rats without and with 5% sucrose removal, respectively.
CONCLUSIONS: Short-term (3-week induction) diabetes- and polyuria-induced functional and morphological alterations of the bladder can mostly be reversed in rats.
© 2015 The Japanese Urological Association.

Entities:  

Keywords:  bladder; diabetes; insulin; morphology; smooth muscle

Mesh:

Substances:

Year:  2015        PMID: 25588853     DOI: 10.1111/iju.12695

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  6 in total

Review 1.  Modulation of lower urinary tract smooth muscle contraction and relaxation by the urothelium.

Authors:  Donna Sellers; Russ Chess-Williams; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-05-28       Impact factor: 3.000

2.  Smooth muscle-specific deletion of MnSOD exacerbates diabetes-induced bladder dysfunction in mice.

Authors:  Rania A Elrashidy; Michael Kavran; Mervat E Asker; Hoda E Mohamed; Firouz Daneshgari; Guiming Liu
Journal:  Am J Physiol Renal Physiol       Date:  2019-06-26

3.  Human amniotic fluid stem cell therapy can help regain bladder function in type 2 diabetic rats.

Authors:  Ching-Chung Liang; Steven W Shaw; Yung-Hsin Huang; Tsong-Hai Lee
Journal:  World J Stem Cells       Date:  2022-05-26       Impact factor: 5.247

4.  Functional and morphological alterations of the urinary bladder in type 2 diabetic FVB(db/db) mice.

Authors:  Liyang Wu; Xiaodong Zhang; Nan Xiao; Yexiang Huang; Michael Kavran; Rania A Elrashidy; Mingshuai Wang; Firouz Daneshgari; Guiming Liu
Journal:  J Diabetes Complications       Date:  2016-03-08       Impact factor: 2.852

Review 5.  Established and emerging treatments for diabetes-associated lower urinary tract dysfunction.

Authors:  Betül R Erdogan; Guiming Liu; Ebru Arioglu-Inan; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-05-12       Impact factor: 3.195

6.  Experimental long-term diabetes mellitus alters the transcriptome and biomechanical properties of the rat urinary bladder.

Authors:  Emad A Hindi; Craig J Williams; Leo A H Zeef; Filipa M Lopes; Katie Newman; Martha M M Davey; Nigel W Hodson; Emma N Hilton; Jennifer L Huang; Karen L Price; Neil A Roberts; David A Long; Adrian S Woolf; Natalie J Gardiner
Journal:  Sci Rep       Date:  2021-07-30       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.